Figure 2.

Differentially regulated proteins in the synovial fluid of female OA patients. (a) Tenascin C, (b) Lysine-Specific Demethylase 2B, (c) Leucine-Rich Repeat-Containing Protein 17, (d) T-Complex Protein 1, (e) Coagulation Factor X, (f) Presenilin, (g) Prostaglandin D2 synthase, (h), Tubulointerstitial Nephritis Antigen, and (i) Nuclear Receptor Binding SET domain protein 1. Differences between normal and OA patients were examined using the empirical Bayes moderated test [non-OA (n = 13) and OA (n = 15) patients, * p value = 0.04].